Dimerix Limited (ASX:DXB)
0.2400
-0.1500 (-38.46%)
Apr 28, 2026, 4:17 PM AEST
Dimerix Earnings Call Transcripts
Fiscal Year 2025
-
Phase three trial for DMX-200 in FSGS is nearing full recruitment, with strong interim results and regulatory engagement for accelerated approval. Four global partners support commercialization, and significant cash reserves enable ongoing development and expansion.